RegMed Investors <RMi> is the news portal focused on providing value-added intelligence, insight and pricing synthesis of stem and cell therapy companies demonstrating real progress toward their vision and meeting quarterly expectation. Now in our twelve year, we aggregate, curate and create bottom-line content weeding of regenerative medicine and cell therapy news to provide a customized, vetted selection of relevant and high-impact synthesis.
